LEIDEN, Netherlands, March 12, 2023 /PRNewswire/ Pharming Group N.V. ("Pharming" or "the Company")( Euronext Amsterdam: PHARM) (Nasdaq: PHAR) is aware that the Federal Deposit Insurance Corporation
LEIDEN, Netherlands, Feb. 28, 2023 /PRNewswire/ Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM) (Nasdaq: PHAR) confirms it will announce its unaudited Full Year
The multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency LEIDEN, Netherlands, Feb. 21, 2023 /PRNewswire/
/PRNewswire/ Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM)/(Nasdaq: PHAR) announces that the first patient has been enrolled.
/PRNewswire/ Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM) (Nasdaq: PHAR) announces that the European Medicines Agency s.